Abstract:ABSTRACT Aims/hypothesis Insulin production and its regulated exocytosis by pancreatic islet beta cells is the major physiological mechanism controlling blood glucose concentrations. Beta cells are susceptible to failure due to genetic and environmental influences, leading to type 1 and 2 diabetes. In this work we aimed to advance understanding of the regulation of beta-cell function by identifying small molecule modulators of secretion. Methods For high-throughput screening and routine medium-throughput beta cell function assays we used mouse MIN6 beta cells stably expressing a Gaussia luciferase-linked insulin secretion reporter (InsGLuc-MIN6). We validated hit small molecules using cadaveric human islets in static culture insulin secretion assays. We measured effects on calcium influx and cAMP in MIN6 cells using Fura-2 and a bioluminescence resonance energy transfer reporter assay, respectively. Metabolism was analyzed by targeted metabolomics and Seahorse oxygen consumption assays. We measured relative gene expression and protein amounts by quantitative RT-PCR and SDS-PAGE immunoblotting, respectively. Results Through our high-throughput screen we discovered 2-(3-benzyl-2-iminobenzimidazol-1-yl)-1-thiophen-2-ylethanol (SW016789) which acutely potentiated nutrient-induced calcium influx and insulin secretion. More than 2 hours of exposure to SW016789 transiently induced the unfolded protein response of the endoplasmic reticulum and shut down of insulin secretory function. Distinct from the effects of thapsigargin, SW016789 did not affect beta cell viability or death as determined by multiplexed cytotoxicity assays and a lack of induction of cleaved PARP. This may be due in part to a more rapid induction of Hspa5 , and a lesser induction of signalling through the eIF2α kinase PERK and lack of expression of oxidative stress genes like Txnip . We determined that SW016789 acted upstream of the voltage-dependent calcium channel (VDCC) and potentiated nutrient-stimulated, but not KCl-stimulated, calcium influx. The potentiating effects of SW016789 were not due to altered metabolic pathways, mitochondrial function, or actions on G protein-coupled receptors. In chemical co-treatment experiments we discovered synergy between SW016789 and small molecule activators of protein kinase C and VDCCs, suggesting potential involvement of these pathways in the mechanism of action. Finally, chronically elevated calcium influx was required for the inhibitory impact of SW016789, as co-treatment with dihydropyridine-class VDCC inhibitors protected MIN6 beta cells and human islets from loss of function. Conclusions/interpretation These data suggest the major mechanism of action of SW016789 in beta cells is to potentiate opening of VDCCs. This activity may partially depend on protein kinase C. Beta cells under pharmacological hypersecretory conditions have the capacity to suppress their function to mitigate ER stress and avoid apoptosis. Further study of the mechanisms underlying these processes will increase understanding of beta cell function in normal and pathophysiological states. Research in context What is already known about this subject? Pharmacologic and environmental chemicals can stimulate aberrant beta cell activity. Hypersecretion of insulin from pancreatic beta cells can cause ER stress and lead to beta cell dysfunction. Defects in beta cell ER stress handling contribute to diabetes pathogenesis. What is the key question? Can the chemical tool SW016789 help uncover novel insulin secretion regulatory pathways and ER proteostasis factors? What are the new findings? SW016789 caused hypersecretion of insulin via enhanced nutrient-stimulated Ca 2+ influx followed by transient ER stress and shutdown of beta cell function without apoptosis. Blockade of voltage-dependent Ca 2+ channels protected human islets and beta cells from hypersecretion-induced dysfunction. How might this impact on clinical practice in the foreseeable future? These results have the potential to uncover beta cell ER stress mitigation factors and add support to beta cell rest strategies to preserve function.

The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β‐cells

Targeted Pharmacological Therapy Restores Beta-Cell Function For Diabetes Remission

Role of Peroxisome Proliferator-Activated Receptor Gamma in Glucose-Induced Insulin Secretion

An insight into the mechanistic role of (-)-Ampelopsin F from Vatica chinensis L. in inducing insulin secretion in pancreatic beta cells

Small molecule-mediated insulin hypersecretion induces transient unfolded protein response and loss of function in pancreatic islet beta cells

Effect of Resveratrol on Glucose-Stimulated Insulin Secretion in Isolated Rat Pancreatic Islets

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

A-064 Improved Insulin production in Advanced glycation end-products (AGEs)-induced RIN-m5F pancreatic β-cells by using a Flavonoid-Rich Medicinal Plant, Kaempferia parviflora treatment

Carnosine scavenging of glucolipotoxic free radicals enhances insulin secretion and glucose uptake

Apigenin Alleviates Endoplasmic Reticulum Stress-Mediated Apoptosis in INS-1 β-Cells

In vitro comparison of various antioxidants and flavonoids from Rooibos as beta cell protectants against lipotoxicity and oxidative stress-induced cell death.

G-Rh4 improves pancreatic β-cells dysfunction in vivo and in vitro by increased expression of Nrf2 and its target genes

Identification of Insulin As a Novel Retinoic Acid Receptor‐related Orphan Receptor Α Target Gene

Ginsenoside Re Reduces Insulin Resistance Through Inhibition Of C-Jun Nh2-Terminal Kinase And Nuclear Factor-Kappa B

Hydroxyhydroquinone and Quassinoids as Promising Compounds with Hypoglycemic Activity through Redox Balance

Small Molecule-mediated Insulin Hypersecretion Induces Transient ER Stress Response and Loss of Beta Cell Function

Flavokawain B is an effective natural peroxisome proliferator-activated receptor γ-selective agonist with a strong glucose-lowering effect

Stimulation of insulin secretion induced by low 4-cresol dose involves the RPS6KA3 signalling pathway

Pharmacological Reduction of NEFA Restores the Efficacy of Incretin-Based Therapies Through GLP-1 Receptor Signalling in the Beta Cell in Mouse Models of Diabetes.

Apigenin potentiates glucose-stimulated insulin secretion through the PKA-MEK kinase signaling pathway independent of K-ATP channels

Effects of chemical constituents of Crossostephium chinense on insulin secretion in rat islets in vitro